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Lipoprotein lipase is frequently overexpressed or translocated
in cervical squamous cell carcinoma and promotes invasiveness
through the non-catalytic C terminus
SA Carter1,2, NA Foster2, CG Scarpini1,2, A Chattopadhyay2, MR Pett1,2, I Roberts2 and N Coleman*,1,2
1Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK; 2Medical Research Council Cancer Cell Unit,
Hutchison-MRC Research Centre, Cambridge CB2 0XZ, UK
BACKGROUND: We studied the biological significance of genes involved in a novel t(8;12)(p21.3;p13.31) reciprocal translocation
identified in cervical squamous cell carcinoma (SCC) cells.
METHODS: The rearranged genes were identified by breakpoint mapping, long-range PCR and sequencing. We investigated gene
expression in vivo using reverse-transcription PCR and tissue microarrays, and studied the phenotypic consequences of forced gene
overexpression.
RESULTS: The rearrangement involved lipoprotein lipase (LPL) and peroxisome biogenesis factor-5 (PEX5). Whereas LPL–PEX5 was
expressed at low levels and contained a premature stop codon, PEX5–LPL was highly expressed and encoded a full-length chimeric
protein (including the majority of the LPL coding region). Consistent with these findings, PEX5 was constitutively expressed in normal
cervical squamous cells, whereas LPL expression was negligible. The LPL gene was rearranged in 1 out of 151 cervical SCCs, whereas
wild-type LPL overexpression was common, being detected in 10 out of 28 tissue samples and 4 out of 10 cell lines. Forced
overexpression of wild-type LPL and PEX5–LPL fusion transcripts resulted in increased invasiveness in cervical SCC cells, attributable
to the C-terminal non-catalytic domain of LPL, which was retained in the fusion transcripts.
CONCLUSION: This is the first demonstration of an expressed fusion gene in cervical SCC. Overexpressed wild-type or translocated LPL
is a candidate for targeted therapy.
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Cervical carcinoma is the third most common cause of cancer
deaths in women worldwide, with approximately 500 000 new cases
and 300 000 deaths per annum (Baldwin et al, 2003). Eighty
percent of cases are squamous cell carcinomas (SCCs), which arise
in a multistep fashion from precursor squamous intra-epithelial
lesions (Arends et al, 1998; Holowaty et al, 1999; Pett and Coleman,
2007). Unlike most other malignancies, cervical carcinoma has a
single causative agent, high-risk human papillomavirus (HR-HPV;
Bosch et al, 1995; Walboomers et al, 1999). However, HR-HPV
infection is insufficient for malignant progression, with host
genomic instability also thought to be required (zur Hausen, 2000).
Chromosomal instability is the most common form of genomic
instability in cervical cancer, with malignant progression being
associated with increasing levels of both structural and numerical
chromosomal abnormalities (Heselmeyer et al, 1996; Harris et al,
2003; Rao et al, 2004; Hidalgo et al, 2005; Lockwood et al, 2007).
The specific host chromosomal abnormalities that drive progres-
sion of cervical SCC remain poorly understood. It is likely that these
include gene fusions caused by chromosomal translocations, which
are increasingly being recognised as important in solid tumours
(Tomlins et al, 2005; Soda et al, 2007; Edwards, 2010). We previously
undertook a systematic molecular cytogenetic analysis of cervical
SCC cells to identify potential driver genes in cervical carcino-
genesis (Foster et al, 2009). The work revealed a novel reciprocal
translocation t(8;12)(p21;p12), which was present in 100% of
metaphases of the cell line MS751. This cell line is hypo-tetraploid,
presumably having undergone endoreduplication followed by
chromosome loss (Ganem et al, 2007). The translocation was
duplicated in all cells, indicating that it occurred before
endoreduplication. In addition, at least one derivative chromo-
some formed by the translocation was present in independent
karyotypic analyses of MS751 cells (Dowen et al, 2003; Harris et al,
2003). Together, these findings indicated that the t(8;12) transloca-
tion was either present in the tumour from which MS751 was
derived, or was acquired early in the establishment of the cell line
in vitro. Abnormalities in the latter category may also be of
significance in cervical carcinogenesis, as chromosomal abnorm-
alities that develop in HR-HPV-infected cell lines in vitro often
reflect those seen in clinical samples, presumably because similar
selective pressures apply in vivo and in vitro (Pett et al, 2004).
In view of these observations, we sought to identify whether the
t(8;12) translocation in MS751 involved gene(s) of broad
functional significance in cervical carcinogenesis. This approach
was justified, as recurrent fusions of importance in cancer, such as
ELM4–ALK, were previously identified following investigation of
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individual cases (Soda et al, 2007). We demonstrated two novel
fusion genes that were produced by the translocation in MS751,
one of which, peroxisome biogenesis factor-5–lipoprotein lipase
(PEX5–LPL), led to the identification of LPL as a recurrently
overexpressed potential oncogene in cervical SCC.
MATERIALS AND METHODS
Cervical SCC cell lines and tissue samples
The cervical SCC cell lines studied were the following: C33A, C-4I,
C-4II, CaSki, DoTc2, HT-3, ME180, MS751, SiHa and SW756. Full
details are given elsewhere (Ng et al, 2007). All cells were obtained
from the American Type Culture Collection and grown in Glasgow
minimum essential medium, 10% fetal calf serum (FCS), 1 Uml 1
penicillin and 1 mgml 1 streptomycin. The FCS was a source of
lipoproteins in functional studies of the cell lines.
All tissue samples were anonymised and used with approval
from the relevant Local Research Ethics Committees. The samples
used were: (i) normal cervical squamous epithelium microdis-
sected from 5 hysterectomy specimens removed for non-neoplastic
disease unrelated to the cervix and (ii) 28 primary cervical SCCs
obtained from the archives of the Kidwai Memorial Institute of
Oncology, Bangalore, India (Ng et al, 2007). In addition, we used
three tissue microarrays (TMAs), namely CXC1501 and CXC1021
(Pantomics, Richmond, CA, USA), and CR803 (Biomax, Rockville,
MD, USA). Together, these contained 12 separate normal cervical
epithelium samples and 151 separate primary cervical SCCs.
Fluorescence in situ hybridisation
Bacterial artificial chromosome (BAC) and fosmid clones were
obtained from BACPAC Resources (Oakland, CA, USA;
Supplementary Tables S1 and S2), and DNA extracted as described
previously (Shing et al, 2003). Whole-chromosome-specific probes
were generated by amplifying flow-sorted chromosomes, using
degenerate oligonucleotide-primed PCR and labelling directly with
Spectrum Orange dUTP (Vysis, Downers Grove, IL, USA). The
BAC and fosmid probes were labelled by nick translation (Vysis)
with either digoxigenin 11-dUTP or biotin 16-dUTP (Roche, Basel,
Switzerland). Avidin-Cy3 or -Cy5 (1 : 400; Amersham, Little
Chalfont, UK) and biotin anti-avidin (1 : 300) were used to detect
biotin-labelled probes, whereas anti-digoxigenin FITC (1 : 500;
Boehringer Mannheim, Mannheim, Germany), rabbit anti-FITC
(1 : 300) and goat anti-rabbit-FITC were used to detect digox-
igenin-labelled probes.
Metaphase BAC fluorescence in situ hybridisation (FISH) was
performed as described previously (Ng et al, 2007). For fibre FISH,
DNA fibres were prepared by lysing cells in 75mM KCl (20min,
37 1C) and fixing in 3 : 1 methanol : acetic acid. The cell suspension
was spread horizontally across a glass slide, which was immedi-
ately immersed in lysis buffer (0.5% (w/v) SDS, 50mM EDTA, 0.2 M
Tris-HCl (pH 7.4); 5min) in a Coplin jar. Ethanol (94%) was added
dropwise above the lysis buffer, and slides incubated for 10min to
precipitate DNA at the solution interface. Slides were removed
from the Coplin jar slowly at an angle to spread DNA fibres along
the slide, incubated in 70% ethanol (30min) to fix fibres to the
slide, and dehydrated through an ethanol series before air drying
and storing at 37 1C. Probes (prepared as for metaphase BAC
FISH) were denatured for 10min at 72 1C and pre-annealed at
37 1C for 30–60min. Fibre slides were prepared by incubating
(3min each) in denaturation solution (0.5 M NaOH, 1.5 M NaCl),
neutralisation solution (0.5 M Tris-HCl, 3 M NaCl) and 2 standard
saline citrate, before dehydrating through an ethanol series, air
drying and storing at 37 1C. Hybridisation of the probe to the DNA
fibres was performed at 37 1C in a dark humidified box for 24 h.
Post-hybridisation washes and detection were performed as for
metaphase BAC FISH. Fluorescent in situ hybridisation on TMAs
was performed as described previously (Shing et al, 2003).
Images were captured with an Axioplan II fluorescence
microscope (Zeiss, Welwyn Garden City, UK) equipped with a
charge-coupled device camera (Applied Spectral Imaging, Carls-
bad, CA, USA), controlled by SmartCapture software (Vysis). For
metaphase and fibre FISH, at least 10 images were captured. For
each TMA, 5 images were taken across each core, and 60 SCC cell
nuclei scored for each case. The interpretation of intact and split
signals was based on generally accepted guidelines recommended
by Vysis and used for break-apart FISH assays in clinical
laboratories. This approach requires the space between two signals
to be greater than one signal width, to be considered a split signal
(Patel et al, 2005).
Long-range PCR
Genomic DNA was extracted as described previously (Shing et al,
2003). Long-range PCR was used to amplify across the breakpoints
of der(8) (primers 50-TTCACCCAGGACAAGGCCCTT-30 and
50-GGTGAATGTGTGTAAGACGTC-30) and der(12) (primers 50-GC
CCACCTGTATCTTTCACATC-30 and 50-CACTCTGTTACTTTTG
TCTCCTTC-30), using Platinum PCR SuperMix High Fidelity
(Invitrogen, New York, NY, USA). Products were then sequenced,
either directly following gel electrophoresis or following cloning
into TOPO vectors (Invitrogen).
Reverse-transcription PCR
RNA was extracted from cell lines or tissue samples and reverse
transcribed as described previously (Ng et al, 2007). The cDNA
templates were amplified by PCR, to allow qualitative detection
of LPL and PEX5 transcripts. We used AmpliTaq Gold DNA
polymerase (Applied Biosystems, Foster City, CA, USA) and the
primers described in Supplementary Table S3. Products were
cloned into TOPO vectors before sequencing.
Quantitative reverse-transcription PCR (qRT–PCR) was per-
formed as described previously (Ng et al, 2007), using primers
listed in Supplementary Table S4. Expression ratios of test samples
relative to reference were calculated using the comparative Ct
method (Pfaffl, 2001), normalising to four different housekeeping
genes. Ratios were referenced to Universal Reference cDNA
(Stratagene, Santa Clara, CA, USA), which was derived from a
broad range of cell types, including those with abundant LPL
expression (e.g., liver cells). A cervical SCC sample was defined as
showing overexpression of LPL if the mean expression level
(calculated using the four housekeeping genes) was greater than
three s.d. above the mean of the five normal cervix samples.
Generation of stable cell lines expressing wild-type
LPL or fusion genes
LPL, PEX5–LPL and PEX5–LPLvar cDNA were cloned into
pcDNA3.1/zeo(þ ) (Invitrogen) and transfected into SW756 cells
with Lipofectamine 2000 (Invitrogen), 48 h after seeding in
OptiMEM-I (Invitrogen). In parallel experiments, vector-only cells
were generated to act as negative controls. Stably transfected cells
were selected in 100 mgml 1 Zeocin for 3–5 weeks, and stable
colonies pooled. In addition, LPL cDNA was cloned into pcDNA4/
myc-His (Invitrogen) and stably transfected into C33A cells. In the
absence of satisfactory antibodies (data not shown), expression
levels of all transgenes were assessed by qRT–PCR, using primers
specific to the C terminus of LPL (Supplementary Table S4).
Cell phenotype assays
To assess cell proliferation rates, 1.4 104 stably transfected cells
were seeded in 24-well plates, and cell numbers measured at
24-h intervals for 10 days, using a Countess Automated Cell
Counter (Invitrogen). All experiments were performed in triplicate.
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The average growth rate for each cell line was determined over the
24-h periods showing greatest exponential growth.
Cell invasion assays were performed using a Cultrex Basement
Membrane Extract Cell Invasion Assay (Trevigen, Gaithersberg,
MD, USA) according to the manufacturer’s directions. Cells that
had invaded were quantified using Calcein-AM, which is inter-
nalised and cleaved to generate fluorescent free Calcein. Standard
curves were performed for each control and transgene-expressing
cell line, to allow conversion of fluorescence values into cell
numbers. All assays were performed in triplicate.
RESULTS
Mapping reciprocal translocation breakpoints in MS751
identified two novel fusion genes
Initial karyotyping using chromosome painting placed the break-
points of the MS751 reciprocal translocation at 8p21 and 12p12
(Foster et al, 2009). We extended this work by mapping the
breakpoints to nucleotide level, by sequentially performing BAC
FISH on metaphase spreads, fosmid FISH on DNA fibres and long-
range PCR spanning the breakpoints.
We first hybridised BACs (approximately 150 kb in length)
mapping to 1-Mb intervals around the suspected breakpoints,
to metaphases of MS751. This allowed the breakpoint localisation
to be refined to 1-Mb regions in chromosome bands 8p21.3
and 12p13.31 (data not shown). Next, BACs tiling each 1-Mb
region were hybridised to MS751 metaphases, along with whole
chromosome paint for the translocation partner chromosome
(i.e., chromosome 12 for the 8p probes and chromosome 8 for
the 12p probes). Such co-hybridisation enabled the derivative
chromosomes resulting from the reciprocal translocation, der(8)
and der(12), to be distinguished from each other, and from normal
chromosomes 8 and 12. This resolved the breakpoints to 150 kb for
chromosome 8 (the region covered by BAC RP11-70F13, which
split and hybridised to both derivatives; Figure 1A) and 95 kb
for chromosome 12 (the overlapping region covered by BACs
RP11-273B20 and RP11-653C9, which both split; Figure 1B). We
identified two genes at the centre of these regions, namely LPL
(encoding lipoprotein lipase) on chromosome 8 and PEX5
(encoding peroxisomal biogenesis factor 5) on chromosome 12
(Figure 1A and B). Both genes were on the forward DNA strand.
To increase further the resolution of breakpoint mapping, we
used DNA fibres of MS751. These were hybridised with fosmids
(approximately 40 kb in length) tiling the target regions, beginning
with those spanning the genes of interest. The fosmids were
co-hybridised with two other probes mapping to the translocation
partner chromosome. The first was a BAC (labelled blue) that
hybridised to the breakpoint on the translocation partner. Splitting
of this BAC allowed the derivative chromosomes to be distin-
guished from normal chromosomes and also suggested the
distance of the fosmid from the relevant breakpoint. The second
co-hybridised probe was a marker BAC (labelled red) for the
translocation partner, which mapped centromeric to the break-
point. These BACs enabled the der(8) and der(12) to be
distinguished (Figure 2A).
Of the chromosome 8 fosmids used, D11 (Figure 2B) was only
found on der(12) (labelled with the chromosome 12 marker BAC),
whereas H10 (Figure 2B) was only found on der(8) (labelled with
the splitting chromosome 12 BAC, but not with the marker
chromosome 12 BAC). These findings implied that the chromo-
some 8 breakpoint was between the sequences to which fosmids
D11 and H10 mapped (Figure 2A). As the sequences overlapped,
der(8)
der(12)
222M11
Telomere
Telomere
der(12)
der(8)
367L22
CLSTN3 PEX5
185H22 157G21
Centromere
653C9
273B20
789M14
1105O14
262B3
NP_060612 LPL
1 Mb
1 Mb
70F13 131MO2
353K12
Centromere
563N12
Figure 1 Breakpoint mapping by metaphase BAC FISH. The panels show hybridisation to der(8) and der(12) in MS751 metaphase spreads of BAC
probes (labelled blue or green) that mapped to the selected 1-Mb regions on 8p21.3 (A) and 12p13.31 (B). For each probe, the reciprocal chromosome in
the translocation (i.e., chromosome 12 in (A) and chromosome 8 in (B)) was labelled in red. Where a BAC did not hybridise to a derivative chromosome,
the image is not shown. The BACs that hybridised to both der(8) and der(12) (i.e., ‘splitting’ BACs) were the chromosome 8 BAC RP11-70F13 (A) and the
chromosome 12 BACs RP11-273B20 and RP11-653C9 (B).
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we concluded that the chromosome 8 breakpoint was very close to
the centromeric end of D11 or the telomeric end of H10, with the
region of each fosmid that hybridised to the opposite derivative
chromosome being so small that it was undetectable by FISH.
This positioned the breakpoint within the LPL coding sequence
(Figure 2A).
Of the chromosome 12 fosmids used, 6D2 (Figure 2C)
hybridised to both der(8) (labelled with the chromosome 8 marker
BAC) and der(12) (labelled with the splitting chromosome 8 BAC,
but not with the chromosome 8 marker BAC). This indicated
that the chromosome 12 breakpoint was within the sequence to
which the 6D2 fosmid mapped. In addition, the chromosome 12
fosmid 9D2 (Figure 2C) hybridised very close to the site
of hybridisation of the splitting chromosome 8 BAC on
der(12). This suggested that the 9D2 sequence was also in
close proximity to the breakpoint, positioning the breakpoint
towards the centromeric end of the sequence that fosmid 6D2
mapped to. This implied that the chromosome 12 breakpoint
was very close to the 50-end of the PEX5 coding sequence
(Figure 2A).
Next, 15-kb regions were selected around the suspected break-
points on each chromosome, and long-range PCR performed using
primers in these regions (for primer sequences, see Materials and
Methods). We sought to amplify across the breakpoints on der(8)
and der(12) to obtain DNA for sequencing. This work revealed
that, for der(12), the breakpoints were within intron 3–4 of LPL
and one base into exon 2 of PEX5 (Figure 3A). For der(8), the
breakpoints were in introns 1–2 of PEX5 (17 bases more telomeric
than the breakpoint in der(12)) and in intron 3–4 of LPL (11 bases
more telomeric than the breakpoint in der(12); Figure 3B).
Therefore, the reciprocal t(8;12)(p21;p13) translocation in MS751
created two novel fusion genes, PEX5–LPL on der(8) and LPL–
PEX5 on der(12).
PEX5–LPL was expressed at higher levels from the
PEX5 promoter
We used RT–PCR to show that both fusion genes were transcribed
in MS751 (Figure 4A). Sequencing the LPL–PEX5 PCR product
demonstrated that splicing occurred from the 30-end of LPL exon 3
into LPL intron 3–4, just before the LPL breakpoint, presumably
because the first base of PEX5 exon 2 was absent (Figure 4B). The
sequence of the cryptic splice acceptor site used in intron 3–4 was
very similar to the splice acceptor consensus sequence and
included the essential AG immediately upstream (Supplementary
Figure S1A; Lodish et al, 2003). This splicing event resulted in a
frameshift in the PEX5 coding sequence, causing a premature stop
codon (Supplementary Figure S1A). Accordingly, the LPL–PEX5
fusion transcript could only be translated into a truncated
chimeric protein.
Chromosome 8
D11
H10
1C11
131M02
Fosmid
BAC 273B20
6D2
Chromosome 12
9D2
PEX5
Telomere
A10
185H22
Centromere
GeneLPL
Telomere
D11
H10
6D2
9D2
A10
1C11
Telomere
Telomere
Fosmid: D11, H10 or 1C11
Chromosome 12 splitting BAC, RP11-273B20
Centromere
Centromere
der(8)
der(8)
der(12)
der(12)
der(12) marker BAC, RP11-185H22
Fosmid: 6D2, 9D2 or A10
Chromosome 8 splitting BAC, RP11-70F13
der(8) marker BAC, RP11-131M02
Centromere
70F13
Figure 2 Breakpoint mapping by fosmid fibre FISH. (A) The fosmid probes (labelled green) selected for hybridisation to MS751 chromosome fibres
either tiled the genes of interest on chromosome 8 and 12 (LPL and PEX5) or were located centromeric to the breakpoint region, and therefore acted as a
control. The fosmids were co-hybridised with BAC probes that mapped to the breakpoint of the reciprocal chromosome (labelled blue) or centromeric to it
(labelled red). (B) Of the chromosome 8 fosmids, D11 hybridised to der(12) (co-localisation of green signals with both blue and red signals), whereas H10
and 1C11 hybridised to der(8) (co-localisation of green signals with only blue signals). (C) Of the chromosome 12 fosmids, 6D2 split between der(8) and
der(12) (co-localisation of green signals with both blue and red signals on some fibres, and with blue signals alone on other fibres), whereas 9D2 and A10
hybridised to der(12) (co-localisation of green signals with only blue signals). The suspected breakpoint regions on each chromosome determined by fosmid
fibre FISH are shown in panel (A) (red vertical lines).
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Sequencing the PEX5–LPL expression PCR products identified
two alternative transcripts. For the most abundant transcript
(Figure 4A), there was splicing from the 30-end of PEX5 exon 1 into
the 50-end of LPL exon 4. The resulting fusion mRNA consisted of
the first exon of PEX5 followed by exons 4–10 of LPL, enabling
translation of a full-length chimeric protein (Figure 4C). In the
alternative transcript (referred to hereafter as PEX5–LPLvar),
splicing was from within the PEX5 intron 1–2 into LPL exon 4. The
transcript retained the LPL reading frame, and therefore, could
also encode a full-length chimeric protein (Figure 4C). Such alterna-
tive splicing from PEX5 intron 1–2 has previously been documented
for the wild-type transcript (http://www.ensembl.org/Homo_
sapiens/Gene/Summary?g=ENSG00000139197;r=12:7341281-7371170;
Supplementary Figure S1B).
We next used RT–PCR to determine the frequency of expression
of wild-type PEX5 and LPL in a panel of normal cervix tissue
samples (n¼ 5) and cervical SCC cell lines (n¼ 10; Supplementary
Figure S2). The PEX5 gene was expressed ubiquitously, consistent
with the function of its protein product as a peroxisome receptor
(Platta and Erdmann, 2007). In contrast, LPL was expressed at
negligible levels, in keeping with its reported tissue-specific
distribution in heart, muscle and adipose tissue (Mead et al,
2002). In accordance with the constitutive activity of the PEX5
promoter, the expression of PEX5–LPL in MS751 was significantly
higher than that of LPL–PEX5 (Figure 4D). Quantitative RT–PCR
showed that LPL exons downstream of the breakpoint (and
therefore downstream of the PEX5 promoter) were expressed at
approximately 100-fold greater abundance than those upstream of
the breakpoint (and therefore downstream of the LPL promoter).
Available antibodies against LPL were not adequate for western
blot detection of the PEX5–LPL fusion protein (data not shown).
LPL is occasionally rearranged and commonly
overexpressed in cervical SCCs
We tested whether LPL was rearranged and/or overexpressed in
cervical SCC tissue samples. We performed BAC FISH on a TMA of
151 separate cervical SCCs, using differentially labelled pools of
BACs mapping upstream and downstream of LPL (Figure 5A).
Probe splitting was seen in one case, indicating that LPL
rearrangements do occur in vivo, albeit rarely. In contrast, qRT–
PCR showed that wild-type LPL was overexpressed in 10 of 28
cervical SCCs, when compared with 5 cases of normal cervix
(Figure 5B). These data suggested that the same functional
consequences may have resulted from translocation of LPL or
overexpression of wild-type LPL. If so, the phenotypic effects of
PEX5–LPL and full-length LPL in cervical SCC cells were predicted
to be similar.
Overexpression of LPL or PEX5–LPL increased
invasiveness of cervical SCC cells
We determined the phenotypic consequences of overexpression of
PEX5–LPL, PEX5–LPLvar and full-length LPL in SW756, a cervical
SCC cell line with negligible native LPL expression (Supplementary
Figure S2, Figure 6A). For all three transgenes, overexpression had
no effect on cell proliferation (Figure 6B), but did increase
invasiveness through basement membrane extract (Figure 6C). The
greatest effect was seen with overexpression of LPL (Po0.0001),
but both PEX5–LPL and PEX5–LPLvar also produced a significant
increase in invasion (Po0.002). Interestingly, the effect on
invasiveness reflected the level of overexpression achieved,
suggesting that each protein had a similar functional effect on
cell invasiveness.
LPL overexpression also increased invasiveness in C33A, an
independent second cervical SCC cell line with negligible levels of
native LPL expression (Supplementary Figure S2, Figure 6D). The
increase in cellular invasiveness was more modest relative to
untreated control cells, but still significant (Po0.009; Figure 6E)
and was not associated with increased proliferation (Figure 6F).
DISCUSSION
Improved techniques for genome analysis have indicated that
reciprocal chromosomal translocations are common in solid
tumours (Roschke et al, 2003; Kumar-Sinha et al, 2006). To our
knowledge, ours is the first evidence of an expressed fusion gene in
cervical carcinoma. Selection of the t(8;12)(p21;p13) rearrange-
ment in MS751 is attributable to the PEX5–LPL fusion gene on the
der(8) chromosome. The gene encoded a full-length chimeric
protein and was expressed at substantially higher levels than LPL–
PEX5, which encoded a truncated protein. These observations were
in keeping with relevant gene promoter activities in cervical
squamous cells, with PEX5 being transcribed ubiquitously, but LPL
being expressed at negligible levels. It is likely that der(12) was
retained in MS751 cells to prevent loss of essential chromosomal
material.
Following initial identification, the significance of any particular
fusion gene can only be estimated by determining the overall
prevalence in vivo of abnormalities involving one or the other
partner gene – such as the fusion gene itself, other structural
rearrangements or aberrant expression of the wild-type gene(s). In
our TMA BAC FISH study, we observed LPL rearrangement in 1 of
151 cervical SCCs. This is in keeping with other solid tumour gene
fusions, with the ELM4–ALK fusion being observed in as few as
2.7% of cases of non-small cell lung cancers (Perner et al, 2008).
In addition, we may have underestimated the frequency of LPL
LPL LPLPEX5 PEX5
der (12) LPL–PEX5 fusion DNA
LPL intron 3–4 PEX5 intron 1–2 LPL intron 3–4
470465460455450590585580575570565560555 475 480 485
PEX5 exon 2
der(8) PEX5–LPL fusion DNA
1
1
2
2 2
3
3 3
4 1 2
1 4 5 6
3 4
4 5
1 2 1 2
Figure 3 Schematic of breakpoints resulting in LPL-PEX5 and PEX5-LPL fusion genes. Numbered boxes represent exons of LPL (yellow) and PEX5
(green), with red vertical lines indicating the positions of the breakpoints resulting in the LPL-PEX5 (A) and PEX5-LPL (B) fusion genes. The lower panels
show the sequencing traces for each breakpoint; a reverse read in (A) and a forward read in (B).
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rearrangements in vivo, as the resolution of TMA BAC FISH is not
sufficient to detect very small rearrangements. Given the high
prevalence of cervical SCC worldwide, low frequency gene
rearrangements will still contribute to substantial numbers of
cases overall.
Importantly, following our identification of the PEX5–LPL gene
fusion, we showed that wild-type LPL was overexpressed in around
a third of cervical SCCs, relative to normal cervix. Regulation of
LPL expression is complex, involving both transcriptional and
post-transcriptional processes (Mead et al, 2002), and the
mechanism of full-length LPL overexpression in cervical SCC
remains to be determined. Such frequent LPL overexpression
in vivo further supported the evidence that the selective advantage
provided by the reciprocal translocation in MS751 was due to
overexpression of functional exons of LPL. If so, wild-type LPL and
the PEX5–LPL fusion protein would be predicted to have similar
functional roles in cervical SCC.
Although the best-described function of LPL is hydrolysis of
triacylglycerol (triglyceride) and generation of fatty acids (Mead
et al, 2002), PEX5–LPL and PEX5–LPLvar are missing the first
three exons of LPL, and therefore, parts of the N-terminal domain
of the wild-type protein that are essential for such catalytic
function (Semenkovich et al, 1990; Ben-Zeev et al, 1994). In
general agreement with this observation, overexpression of LPL or
the fusion genes in cervical SCC cells did not increase cell growth,
which is a common consequence of increased cellular metabolic
activity (Jones and Thompson, 2009). In contrast, overexpression
of all three transgenes did increase cellular invasion to an extent
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equivalent to transcript abundance. We conclude that the LPL
domain that provided a selective advantage in cervical SCC cells
was likely to be shared between the three transgenes, and
accordingly, was most likely to be in the C-terminal region, which
is essential for many of the non-catalytic functions of LPL.
Interestingly, recurrent overexpression of LPL has also been
observed in chronic lymphocytic leukaemia (CLL), where it is an
adverse prognostic marker (Heintel et al, 2005; Oppezzo et al,
2005). In keeping with our data, overexpressed LPL in CLL is not
associated with increased catalytic activity (Mansouri et al, 2010).
After synthesis in parenchymal cells, LPL passes through the
endoplasmic reticulum and is secreted. It binds heparan sulphate
proteoglycans (HSPG; Braun and Severson, 1992) and is translo-
cated to HSPG-binding sites on the luminal surface of the capillary
epithelium, potentially along a bridge of HSPGs in the extracellular
matrix (Blanchette-Mackie et al, 1989). Non-catalytic functions of
LPL include dimerisation and bridging between lipoproteins and
cell surface receptors such as HSPG (Merkel et al, 1998). Bridging
may involve different cell types, requiring LPL dimerisation and
HSPG on both surfaces (Mamputu et al, 1997; Obunike et al, 1997).
Accordingly, expression of LPL by malignant cells may promote
tumorigenesis by enabling the cell–stromal interactions that are
critical for tumour maintenance (Mansouri et al, 2010).
Importantly, HSPGs are abundant in the extracellular matrix
(ECM) of various malignancies, including carcinomas (Iozzo et al,
1994). Elevated expression of HSPGs has been associated with
increased metastasis and it has been proposed that HSPGs in the
ECM form an adhesive tract for cell migration (Sanderson, 2001).
Our data support a model in which LPL, PEX5–LPL or PEX5–LPLvar,
all sharing the non-catalytic LPL C terminus, bridge between HSPGs
on the cell surface and in the ECM, thereby promoting cell invasion
(Supplementary Figure S3). The PEX5–LPL and PEX5–LPLvar fusion
proteins do not possess the N-terminal signal peptide responsible
for targeting LPL to the endoplasmic reticulum before secretion,
and are therefore unlikely to be processed in the same manner
as full-length LPL. Interestingly, the first exon of PEX5 might
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labelled in green and red, respectively (left panel). The DNA counterstain
(40 ,6-diamidino-2-phenylindole) is shown in grey. Co-localisation of probes
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cervical SCC samples. One cervical SCC sample showed probe separation
(right panel), indicating rearrangement of the LPL gene. Interestingly, this
case also showed deletion of the wild-type LPL allele. (B) Quantitative RT–
PCR to measure levels of full-length LPL was performed on 28 cervical SCC
samples and 5 normal cervical squamous epithelium samples, relative to
Universal Reference cDNA. Error bars indicate the s.e.m. for LPL
expression levels, normalised to four different housekeeping genes. The
dashed line shows 3 standard deviations above the mean of the five normal
samples. Ten tissue samples (left of arrow) showed a significantly higher
level of LPL expression than normal cervix.
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contribute to secretion of the fusion protein, as PEX5 is known to
have intrinsic lipid-binding activity (Kerssen et al, 2006). This is
an attractive and testable model, and indicates the need for further
work to determine how LPL, PEX5–LPL and PEX5–LPLvar contri-
bute to cervical SCC cell invasiveness.
We conclude that LPL is frequently deregulated in cervical SCC,
either because of overexpression of the wild-type gene or, more
rarely, because of translocation, as exemplified by the PEX5–LPL
gene fusion that we identified in MS751. The selective advantage is
provided by the non-catalytic C-terminal domain, which increases
the invasiveness of cervical SCC cells. The functional interactions
of this domain may represent a novel therapeutic target in cervical
SCC and potentially other tumour types.
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